Drug Shortages Turing Pharmaceuticals – Compounding Pharmacy Fights Back Thomas Sullivan Oct 29, 2015 1 Turing Pharmaceutical's purchase of Daraprim from Impax Laboratories in August 2015 for $55 million was followed by a…
Events The Fourth Annual Corporate Compliance & Transparency in the… Thomas Sullivan Oct 29, 2015 0 The Fourth Annual Corporate Compliance & Transparency in the Pharmaceutical Industry, presented by Fleming Europe,…
Congress Hide No Harm Act of 2015: includes Criminal Penalties for Failure to Report… Thomas Sullivan Oct 28, 2015 0 Deputy Attorney General Sally Q. Yates recently announced new guidance that the Department of Justice will focus…
DOJ Novartis Announces $390 Million False Claims Act Settlement on Rebates to… Thomas Sullivan Oct 28, 2015 0 Novartis AG, the world's largest seller of prescription drugs, has announced a $390 million tentative agreement to…
CME CME Back to the Future Thomas Sullivan Oct 27, 2015 0 It is unusual to read an article that critiques CME activities based on evidence that came out after the courses were…
Corporate Integrity Agreements Millennium Health Settlement and Corporate Integrity Agreement: Focus on… Thomas Sullivan Oct 26, 2015 0 Millennium Health has agreed to pay $256 million to resolve allegations that it billed Medicare, Medicaid, and other…
Maintenance of Certification CME that Counts for American Board of Internal Medicine MOC Update Thomas Sullivan Oct 23, 2015 0 In response to requests from physicians and accredited CME providers, the Accreditation Council for Continuing Medical Education…
Congress More Trouble for Valeant Pharmaceuticals Thomas Sullivan Oct 22, 2015 0 Earlier this year, Valeant Pharmaceuticals purchased Nitropress and Isuprel, a pair of life-saving heart drugs. The same day…
Uncategorized EMA Announces Publication of Clinical Trial Reports By Middle of 2016 Thomas Sullivan Oct 21, 2015 0 The European Medicines Agency (EMA) announced it is moving forward with its plan to release the clinical data used in marketing…
Medical Legal FDA Removes Pacira Warning Letter in Midst of Free Speech Suit Thomas Sullivan Oct 21, 2015 0 We have previously written about Pacira Pharmaceuticals, Inc. and their constitutional challenge against the Food and Drug…